AllCells - San Francisco Bay Area

AllCells - San Francisco Bay Area

Alameda, California

AllCells Advantage


AllCells is the leading provider of high quality human primary blood and marrow-based cells for over 21 years. Expertise and deep experience in the industry has enabled AllCells to optimize protocols and provide assurances that all regulatory protocols have been met for research and clinical grade products are delivered, on-time to pharmaceutical, biotech, medical device, hospitals and academic institutions around the world; while maintaining best in class products and services.

AllCells sources through its on-site, IRB-approved state-of-the-art donor and management facilities, where we collect cells and whole tissue from a large repository of recallable donors which enables custom orders to be fulfilled in the shortest time in the industry. AllCells immediately processes fresh tissue in our adjacent labs to produce purified cell types having unparalleled quality and consistency.

Consistent high viability, high purity subtypes, and guaranteed accurate cell count. AllCells is known for its quality cells and ability to customize based on some of the most unique customer requirements. AllCells – Quality Cells for Quality Science

Our Promise


To continue to pursue our passion for innovation and customer engagement, driven by a deep understanding that high quality starting material is key to better patient outcomes.

The Right Cells

The Right Cells

Superior results start with the right cells:

  • Comprehensive validation protocols
  • Unsurpassed donor screening protocols
  • Catalog covering multiple cell types within Hematology and Immunology, Cell and Gene therapy, Immuno-oncology, Cell Biology, Biomedical Research, and Drug Discovery
  • Customized services to meet project requirements
At the Right Time

At the Right Time

Special orders delivered in three days:

  • On-site blood and marrow tissue collection facilities ensure control of the supply chain
  • Delivered when you need them
  • World-wide service – now delivered faster
  • Easy ordering with real time chat & inventory checks
Made to Order

Made to Order

Flexibility and experience:

  • Cell viability and quantity to product specifications
  • Cell purity to product specifications
  • Delivered as specified, as promised, when needed
  • Clinical Grade for Allogeneic use

History


Founded in 1998, AllCells is a biotechnology company dedicated to providing global researchers and biomanufacturing organizations with a dependable supply of biologically relevant, high quality primary cells that enable drug discovery, development, and manufacturing of cell therapies. Leveraging its expertise in hematology and immunology cell isolations, combined with on-site whole blood and bone marrow tissue collection operations, AllCells maintains direct access to a large repository of diverse donor profiles that can be further screened and qualified for biomedical applications. Utilizing its contiguous cell processing facilities, freshly collected tissue is immediately processed into purified cell types with unparalleled quality consistency. This optimal work-flow provides for the highest viability, purity, and cell count available. Fresh or frozen cells are shipped worldwide, or fresh cells can be immediately utilized in fee-for-service cell-based assays – delivering cell culture results/data to meet client project timelines.

1998 – 2003
  • AllCells Founded in Berkeley, California by Jay Tong, M.D.
  • Published first catalog offering a wide range of products and bioservices
  • Delivered directly to local, domestic and global customers
2003 – 2008
  • Established IRB-approved, state-of-the-art donor facilities to collect cells and whole tissue from a large repository of recallable donors which enables custom orders to be fulfilled in the shortest time in the industry
  • Employed cutting-edge processing tools, such as AutoMACS and CliniMACS
  • Further diversified product portfolio by adding numerous CD34+ isolated cell products and fresh cord blood
2008 – 2013
  • Ranked among the fastest growing privately owned United States companies by Inc. 500
  • Achieved the “Fast 50 Award” award from by the United States Pan Asian American Chamber of Commerce
  • Relocated to AllCells existing Headquarters in Alameda, California
2013 – 2019
  • Began delivering Clinical Grade products to the biomedical research market
  • Grand Opening of AllCells Boston offices
  • Integrated enterprise systems solutions Oracle Netsuite
  • Lonza partnership

Mission


Our mission is to help the researchers we support find breakthroughs in science and improve human health. Our role in that is to make sure that we deliver the highest quality hematology and immunology cell-based products and bioservices consistently, reliably, and affordably.

Our Vision is to:

  • To be the most loved -Most trusted – biotechnology company in the industry
  • Adapt to market trends to meet our customers’ special needs
  • Bring innovation and inspiration to every researcher
  • Deliver quality products and services for life science research and clinical grade applications.
  • Pioneer a new way of ordering cells via AllCells webstore; with an unparalleled and customer-centric approach.

Leadership Team

DR. JAY TONG

Founder and Chairman of the Board

Jay Tong founded AllCells, LLC in 1998 and served as the company’s President & CEO until 2018 when he became Chairman. While working as a Research Scientist at Novartis-Systemix (Palo Alto, CA) in the 1990s, Dr. Tong recognized an industry need for a readily available commercial source of hematologic tissue such as bone marrow, cord & peripheral blood, and purified hematology & immunology primary cell types needed to support scientific research, drug discovery and development. Jay earned his M.D. from Suzhou Medical College in China, and completed graduate studies in Hematology at Henan University at Zheng Zhou. He later completed his Hematology Fellowship at the prestigious Genoa Medical School in Italy, a world leader in bone marrow transplantation. Additional post-doctoral training took Dr. Tong to Dr. Ronald Hoffman’s Lab at Indiana University Medical School at Indianapolis. Dr. Tong has published over thirty (30) peer reviewed papers relating to stem cell purification, ex vivo expansion, gene transduction, and hematopoietic stem cell transplantation.

DON KLABUNDE

Chief Executive Officer

Don Klabunde, CEO, joined AllCells in 2016 with over 30 years of leadership experience. Don has an extensive background in sales, marketing, finance and operations. Don has been especially instrumental in optimizing complex business processes by leveraging enterprise technology, and increasing operational productivity to position AllCells for accelerated growth.

Don is a results-focused leader, widely respected for his strategic insight and commitment to developing high-performing, diverse teams. Don has led high performing teams from angel start-ups to large fortune 500 companies.

TED PARENTI

Vice President Finance

Ted Parenti, Vice President of Finance, joined AllCells in May 2016. Ted brings to AllCells extensive experience in cost accounting, capital investment and budget, and forecast/analysis using ERP systems. Ted has primary responsibility for leading the company’s accounting control, financial reporting, and forecasting processes.
Prior to joining AllCells Ted served as Industrial Controller with Bio-Rad Laboratories, Inc. where he was responsible for financial control covering multiple operational sites within Bio-Rad’s life science division. Ted has held several financial management positions including Cost Accounting Manager at Peet’s Coffee & Tea, Cost Manager with The Clorox Company, Regional Finance Manager with General Mills Operations, Inc., and others.

ROB FRANKENBERG, Phd, PMP, CPIM, CSCP

Vice President Supply Chain

Rob Frankenberg joined AllCells executive team June 20, 2016. Rob brings to AllCells 24+ years of global experience in processing of recombinant biologics, chemicals and diagnostic reagents; optimizing operations, while meeting safety, cGMP and ISO regulations; resolution of complex discrepancies to regulatory expectations through root cause analysis and continuous improvement; providing technical stewardship of operations through management of technology and statistical process control; co-inventing of commercial purification processes; effectiveness in influence management of multiple global contract manufacturing and contract research organizations.

Previously Rob was GMP Operations Manager at Bio-Rad Laboratories, accountable for the operational leadership of Bio-Rad’s GMP clinical diagnostics consumables manufacturing operation representing >$250M in annual sales and a production team of 29 team members and 3 supervisors. He was responsible for operations management within SAP, optimization of resource utilization, project management of continuous improvement, facility startup and expansion initiatives and capital projects. Rob holds Bachelor of Science in Biochemistry (UC Davis), a Ph.D. in Bioengineering (UCSF and UC Berkeley) with a Certificate in Management of Technology (Haas School Of Business), a Project Management Professional (PMP, PMI) Certification, a certification in Production and Inventory Management (CPIM, APICS) and a certification as a Supply Chain Professional (CSCP, APICS).

TIMOTHY C. FONG, PhD, MBA

Vice President, Science and Biotechnology

Tim Fong joined the AllCells executive team March 16, 2017. Tim has over 20 years of biotech industry experience with broad expertise in therapeutic drug discovery and development. Tim has led teams in discovery research, preclinical studies, product characterization, and GMP manufacturing process development in several platform technologies, including cell and gene therapy, bio-active peptides and recombinant protein with a focus on cancer immunotherapy, angiogenesis, autoimmunity, and inflammatory diseases. He has held positions of increasing responsibility at Chiron (Novartis), Aventis Gencell, Sangstat (Genzyme), BD Biosciences, Progenitor Cell Therapy (NeoStem), and Cellerant.

Tim earned his doctorate in Immunology from the Department of Microbiology & Immunology, UCLA School of Medicine, and completed postdoctoral fellowships at the Salk Institute in La Jolla, CA, and at UC San Diego. Tim also holds an MBA from St. Mary’s College, CA. He is a past member of the Product and Process Development and Immunotherapy Committees, International Society for Cell Therapy, and a member of the American Association of Cancer Research, American Society for Hematology, American Association of Immunologists, and Society for Immunotherapy of Cancer.

SHEILA SMITH, RN, BSN, HP (ASCP)

Director, Clinical Operations

Sheila Smith joined AllCells LLC in July 2014. Sheila brings to AllCells over 30 years of clinical experience with emphasis in therapeutic and donor apheresis, immunology and clinical research. Additional experience includes fiscal management, state and federal regulatory compliance, development of standard operating procedures and quality programs.

Prior to joining AllCells, Sheila held the position of Apheresis Regional Manager with Fresenius Medical Care. She was responsible for the operations and clinical oversight of a Northern California mobile apheresis program serving over 65 hospitals and healthcare organizations. Sheila holds a B.S. in Nursing (Grand Valley State College, Allendale, MI) and a Hemapheresis Practitioner Certification through the American Society for Clinical Pathology.

VALERIE GOODWIN-ADAMS, MBA

Director, Marketing

Valerie Goodwin-Adams joined AllCells in 2018 to lead AllCells marketing strategies and growth objectives. Valerie comes with more than 25 years of extensive marketing experience in FDA-regulated biopharma and medical device industries. Prior to joining AllCells, Valerie held the position of Sr. Director of Global Marketing at Abaxis (acquired by Zoetis) for 13 years. Valerie has held marketing positions of increasing responsibility at Agilent Technologies, Dako and Cadence Design Systems.

Valerie holds a B.A. in Communications from San Jose State University, CA, and an MBA from Brigham Young University (BYU) Marriott School of Management, UT.  In addition, Valerie holds a Digital Marketing Certificate from Cornell University.

CHERYL COVERT

Director Quality Assurance & Quality Control

Cheryl Covert joined AllCells in 2017 with more than 25 years of extensive quality management and compliance experience in the FDA-regulated biopharma and medical device industries. Cheryl started her career at Chiron Corporation, (since acquired by Novartis), holding several positions of increasing responsibility in quality and manufacturing. In the 10 years prior to joining AllCells, she was head of Quality Assurance for the Clinical Systems Division at Bio-Rad Laboratories. Ms. Covert directs the quality control and quality assurance processes ensuring AllCells’ Research and Clinical Operations meet applicable domestic and international regulatory requirements.

Cheryl holds a B.S. in Microbiology from San Jose State University, CA, and an MBA from St. Mary’s College, CA.

LISA MARTIN

Director, Sales

Lisa Martin joined AllCells in October 2018. Lisa brings 20+ years of sales experience to AllCells. Lisa has extensive experience in establishing and improving sales processes with a focus on increasing revenue, improving forecasting, and mentoring and coaching sales teams.

Previously, Lisa was the Director of Sales Development at a number of software companies, where she was responsible for the inside sales team as well as managing the sales efficiency tools, developing sales on-boarding processes, and coaching and mentoring the inside sales team. Lisa holds a B.A. in History from UCLA, CA.

Have a question? Let’s chat.